A major rule change from the Food and Drug Administration (FDA) is expected to make abortion induced by medicine, rather than surgery, more common and easier to obtain for women in areas of the country without nearby clinics.
Under the new rule, women who are prescribed abortion medication will only have to visit the doctor twice, instead of three times. The agency also lowered the required dosage of mifepristone from 600 mg to 200 mg, a change that some say will make medical abortions more attractive because the smaller dosage will mean fewer painful side effects.
Even before the FDA announcement, abortion rights advocates were hoping that technological innovation could reduce the impact of the recent wave of state laws that have sought — and in many cases succeeded — to shut down abortion practices.
Recommended For You
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to asset-and-logo-licensing@alm.com. For more information visit Asset & Logo Licensing.
